Lacosamida Jubilant Pharmaceuticals

Lacosamide, the active ingredient in Lacosamida Jubilant Pharmaceuticals, is an anticonvulsant presented as an oral formulation for oral use. It treats partial‑onset seizures in patients with epilepsy.

GNH USA supplies Lacosamida Jubilant Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant used in the management of focal seizure disorders. - Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy. - Focal epilepsy: provides adjunctive therapy for uncontrolled focal seizures. - Refractory epilepsy: used as add‑on treatment when other agents are insufficient.

Common side effects are generally mild to moderate and may resolve with continued therapy.

Common Side Effects: - Dizziness - Fatigue - Nausea - Headache - Diplopia (double vision) - Somnolence

Serious or Rare Side Effects: - Cardiac arrhythmias (e.g., PR‑interval prolongation) - Suicidal ideation or behavior - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Hypersensitivity reactions (rash, angioedema) - Hepatic injury - Blood dyscrasias (e.g., agranulocytosis)

Lacosamide requires careful monitoring in several clinical situations. - Renal impairment: dose adjustment may be needed. - Hepatic impairment: monitor liver function tests. - Cardiac conduction abnormalities: obtain baseline ECG and monitor PR interval. - Pregnancy: safety category unknown; avoid unless benefit outweighs risk. - Concomitant CNS depressants: may increase sedation. - Store at below 25°C: keep in the original pack, protect from moisture.

Lacosamide can interact with several medicines, requiring dose adjustments or monitoring.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide plasma levels. - Carbamazepine: may reduce lacosamide exposure, decreasing efficacy. - Other sodium‑channel blockers (e.g., phenytoin): increased risk of CNS depression.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance dizziness and somnolence. - Additional antiepileptic drugs: monitor seizure control and side‑effect profile. - QT‑prolonging agents: observe ECG for interval changes.